Targeted treatment in COPD: a multi-system approach for a multi-system disease

Area of Science:

• Pulmonology
• Clinical Medicine
• Pathophysiology

Background:

• Chronic obstructive pulmonary disease (COPD) presents with diverse clinical features and disease development factors.
• The heterogeneous nature of COPD may explain treatment limitations in improving mortality and reversing disease progression.
• Varied host responses and clinical phenotypes in COPD are areas of significant recent research interest.

Purpose of the Study:

• To review existing research on COPD phenotyping.
• To evaluate the efficacy of phenotype-specific treatments for COPD.
• To examine pathological processes and clinical manifestations, including pulmonary and systemic effects, focusing on pharmacological therapies.

Main Methods:

• Literature review of studies on COPD phenotyping.
• Analysis of research linking pathological and clinical phenotypes to treatment outcomes.
• Examination of pharmacological interventions for identified COPD phenotypes.

Main Results:

• The review identifies various approaches to phenotyping COPD.
• Evidence for the benefit of targeted treatments for specific COPD phenotypes is assessed.
• The article synthesizes findings on pulmonary and systemic manifestations and their relation to treatment.

Conclusions:

• COPD's heterogeneity necessitates a move towards personalized medicine.
• Identifying and treating specific COPD phenotypes holds promise for improved patient outcomes.
• Further research into targeted pharmacological therapies for distinct COPD phenotypes is warranted.